CoreFirst Bank & Trust - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
CoreFirst Bank & Trust ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2022$3,167
-64.8%
203
-71.2%
0.00%
-75.0%
Q3 2022$9,000
-30.8%
706
-21.2%
0.01%
-20.0%
Q2 2022$13,000
-90.3%
896
-90.4%
0.01%
-89.1%
Q1 2022$134,000
+4.7%
9,3460.0%0.09%
+10.8%
Q4 2021$128,000
-16.9%
9,3460.0%0.08%
-22.4%
Q3 2021$154,000
+77.0%
9,346
+80.7%
0.11%
+81.4%
Q2 2021$87,000
-7.4%
5,1730.0%0.06%
-9.2%
Q1 2021$94,0000.0%5,1730.0%0.06%
-7.1%
Q4 2020$94,0005,1730.07%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders